Which program is used to manage isotretinoin risk?

Prepare for the CPJE Law Test. Explore flashcards and multiple choice questions with detailed explanations. Ace your exam with comprehensive prep!

Protecting against birth defects from isotretinoin is handled through a dedicated risk management program, iPledge. This program ensures that every patient, prescriber, and pharmacy is enrolled and that strict safety steps are followed before isotretinoin can be dispensed. Key elements include enrollment of all parties, confirmation of pregnancy status (for those who could become pregnant), mandatory contraception for women of childbearing potential, regular pregnancy testing, and monthly verification before each prescription fill. Dispensing is tightly controlled to enforce compliance and limit risk.

The other options refer to REMS programs for different drugs with their own safety concerns, not isotretinoin. Clozapine REMS is for monitoring serious blood disorders with clozapine, while Addyi and Saxenda have their own risk-management considerations unrelated to isotretinoin.